FDA orders 4 firms to stop selling unapproved codeine products

10/13/2009 | United Press International

The FDA sent warning letters prohibiting Glenmark Generics, Lehigh Valley Technologies, Cerovene and Dava International from marketing unapproved codeine sulfate tablets as a treatment for pain. The agency gave manufacturers 90 days to halt production, and distributors have 180 days to stop shipment.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA